ArticleMedical devices (Auckland, N.Z.)2017
An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models.
Article in Medical devices (Auckland, N.Z.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 39 citations in OpenAlex.
- Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisTrial
- Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisTrial
- Association of oxidized regenerated cellulose powder and tranexamic acid during total knee arthroplasty: clinical outcomes.International orthopaedics · 2026Article
- Development of a Rapid-Acting Oxidized Regenerated Cellulose-Based Powder for Hemostatic Applications.ACS omega · 2026Article
- Considerations About the Antimicrobial Activity of Oxidized Cellulose and Oxidized Regenerated Cellulose and Their Potential Application in Veterinary Surgery.Veterinary sciences · 2026Review
- Oxidized regenerated cellulose particles enable high-pressure air-leak sealing on lung segmentectomy surfaces in porcine models.Frontiers in bioengineering and biotechnology · 2026Article
- Highly Absorbent Ultrafast Self-Gelling Starch Microparticles for Robust Wet-Tissue Adhesion and Instant Hemostasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- The efficacy of oxidised regenerated cellulose powder in reducing blood loss during primary total hip arthroplasty: a retrospective cohort study.Journal of orthopaedic surgery and research · 2025Article
- Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations.Research and practice in thrombosis and haemostasis · 2025Article
- Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat.Medical devices (Auckland, N.Z.) · 2024Review
- Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding.BMC surgery · 2022Article
- New polyoxazoline loaded patches for hemostasis in experimental liver resection.Journal of biomedical materials research. Part B, Applied biomaterials · 2022Article
- Article
- Biological compatibility of oxidized cellulose vs. porcine gelatin to control bleeding in liver lesions in rats.Acta cirurgica brasileira · 2022Article
- Engineering a naturally derived hemostatic sealant for sealing internal organs.Materials today. Bio · 2022Article
- An international multidisciplinary peer-driven consensus on the optimal use of hemostatic powders in surgical practice.Updates in surgery · 2021Article
- Comparison of the efficacy of five standard topical hemostats: a study in porcine liver and spleen models of surgical bleeding.BMC surgery · 2020Article
- Traumastem Powder in Treatment of Non-Traumatic Anterior Epistaxis in Emergency Department; a Randomized Clinical Trial.Archives of academic emergency medicine · 2020Article
- Absorbable hemostatic hydrogels comprising composites of sacrificial templates and honeycomb-like nanofibrous mats of chitosan.Nature communications · 2019Article
- Safety and Efficacy of a Novel Hemostatic Powder in Total Knee Arthroplasty.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUsage of topical hemostatic agents in surgery is increasing, including use during minimally invasive procedures, and even for surgeries that have a low risk of bleeding complications. A novel product, Surgicel
methodsHemostatic efficacy of SP was compared to two polysaccharide-based hemostats in a porcine liver punch biopsy model and to three polysaccharide-based hemostats and one non-regenerated oxidized cellulose hemostat in a porcine liver abrasion model. Primary outcomes measured were hemostatic efficacy, defined as hemostasis within 10 minutes of application, and time-to-hemostasis (TTH).
resultsIn the punch biopsy model, SP displayed significantly higher effective hemostasis rates than one of the polysaccharide hemostats (
conclusionIn both the liver punch biopsy model of mild to moderate bleeding and the liver abrasion model of mild but diffuse oozing, SP provided more effective hemostasis and faster TTH than other marketed hemostatic powders. The results from this in vivo study suggest that Surgicel Powder may be useful in clinical applications where control of oozing capillary, mild venous, and small arterial hemorrhage is required including bleeding in difficult-to-access locations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.